Jaguar Health stock swings as Future Pak licensing deal dangles $38 million — here’s what traders see
New York, January 12, 2026, 10:25 EST — Regular session Jaguar Health, Inc (NASDAQ: JAGX) shares dropped roughly 9% Monday after announcing a U.S. licensing deal with an affiliate of private company Future Pak, potentially generating up to $38 million for its crofelemer products. The stock last traded near $0.96, after earlier surging as much as 38%, fluctuating between $0.94…